EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Disruption of Super‐Enhancers in Activated Pancreatic Stellate Cells Facilitates Chemotherapy and Immunotherapy in Pancreatic Cancer

Yazhou Wang iD, Kai Chen, Gang Liu, Chong Du, Zhaoxia Cheng, Dan Wei, Fenfen Li, Chen Li, Yinmo Yang, Ying Zhao, Guangjun Nie

Advanced Science · 2024

DOI: 10.1002/advs.202308637 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2024. Verfasst von Yazhou Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Pancreas Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210000, China. Hauptthemen laut MEDLINE: Pancreatic Stellate Cells, Pancreatic Neoplasms, Immunotherapy, Tumor Microenvironment. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation, Beijing Nova Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

One major obstacle in the drug treatment of pancreatic ductal adenocarcinoma (PDAC) is its highly fibrotic tumor microenvironment, which is replete with activated pancreatic stellate cells (a‐PSCs). These a‐PSCs generate abundant extracellular matrix and secrete various cytokines to form biophysical and biochemical barriers, impeding drug access to tumor tissues. Therefore, it is imperative to develop a strategy for reversing PSC activation and thereby removing the barriers to facilitate PDAC drug treatment. Herein, by integrating chromatin immunoprecipitation (ChIP)‐seq, Assays for Transposase‐Accessible Chromatin (ATAC)‐seq, and RNA‐seq techniques, this work reveals that super‐enhancers (SEs) promote the expression of various genes involved in PSC activation. Disruption of SE‐associated transcription with JQ1 reverses the activated phenotype of a‐PSCs and decreases stromal fibrosis in both orthotopic and patient‐derived xenograft (PDX) models. More importantly, disruption of SEs by JQ1 treatments promotes vascularization, facilitates drug delivery, and alters the immune landscape in PDAC, thereby improving the efficacies of both chemotherapy (with gemcitabine) and immunotherapy (with IL‐12). In summary, this study not only elucidates the contribution of SEs of a‐PSCs in shaping the PDAC tumor microenvironment but also highlights that targeting SEs in a‐PSCs may become a gate‐opening strategy that benefits PDAC drug therapy by removing stromal barriers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic Stellate CellsPancreatic NeoplasmsImmunotherapyTumor MicroenvironmentCarcinoma, Pancreatic DuctalHumansAnimalsMiceDisease Models, AnimalGemcitabineDeoxycytidineAzepinesCell Line, TumorTriazoles

Stichwörter der Autor:innen

activated pancreatic stellate cellscombination therapypancreatic cancersuper‐enhancer

Substanzen

(+)-JQ1 compoundGemcitabineDeoxycytidineAzepinesTriazoles

Autor:innen und Institutionen

  • Pancreas Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210000, China.
  • CAS Key Laboratory for Biomedical Effects of Nanomaterials & Nanosafety, CAS Center of Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing, 100190, China.
  • Department of General Surgery, Peking University First Hospital, Beijing, 100034, China.
  • Key Laboratory of Molecular Epigenetics of the Ministry of Education, Northeast Normal University, Changchun, 130024, China.
  • Department of Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, China.

ORCID-Profile: Yazhou Wang

Förderung

  • National Natural Science Foundation of China
  • China Postdoctoral Science Foundation
  • Beijing Nova Program
  • Natural Science Foundation of Beijing Municipality
  • Youth Innovation Promotion Association of the Chinese Academy of Sciences
  • Special Project for Research and Development in Key areas of Guangdong Province

Zitieren

APA

Wang, Y., Chen, K., Liu, G., Du, C., Cheng, Z., Wei, D., Li, F., Li, C., Yang, Y., Zhao, Y., & Nie, G. (2024). Disruption of Super‐Enhancers in Activated Pancreatic Stellate Cells Facilitates Chemotherapy and Immunotherapy in Pancreatic Cancer. Advanced Science. https://doi.org/10.1002/advs.202308637

Vancouver

Wang Y, Chen K, Liu G, Du C, Cheng Z, Wei D, et al. Disruption of Super‐Enhancers in Activated Pancreatic Stellate Cells Facilitates Chemotherapy and Immunotherapy in Pancreatic Cancer. Advanced Science. 2024. doi:10.1002/advs.202308637

BibTeX
@article{Wang2024,
  author = {Wang, Yazhou and Chen, Kai and Liu, Gang and Du, Chong and Cheng, Zhaoxia and Wei, Dan and Li, Fenfen and Li, Chen and Yang, Yinmo and Zhao, Ying and Nie, Guangjun},
  title = {Disruption of Super‐Enhancers in Activated Pancreatic Stellate Cells Facilitates Chemotherapy and Immunotherapy in Pancreatic Cancer},
  journal = {Advanced Science},
  year = {2024},
  doi = {10.1002/advs.202308637}
}
Kostenlos starten →